CALL FOR PAPERS Programming Normal Renal Development and Modeling Disease Pathogenesis Role of the USF1 transcription factor in diabetic kidney disease

Sanchez AP, Zhao J, You Y, Declèves A-E, Diamond-Stanic M, Sharma K. Role of the USF1 transcription factor in diabetic kidney disease. Am J Physiol Renal Physiol 301: F271–F279, 2011. First published May 4, 2011; doi:10.1152/ajprenal.00221.2011.—The predominant transcription factors regulating key genes in diabetic kidney disease have not been established. The transcription factor upstream stimulatory factor 1 (USF1) is an important regulator of glucosemediated transforming growth factor (TGF)1 expression in mesangial cells; however, its role in the development of diabetic kidney disease has not been evaluated. In the present study, wild-type (WT; USF1 / ), heterozygous (USF1 / ), and homozygous (USF1 / ) knockout mice were intercrossed with Akita mice (Ins2/Akita) to induce type 1 diabetes. Mice were studied up to 36 wk of age. The degree of hyperglycemia and kidney hypertrophy were similar in all groups of diabetic mice; however, the USF1 / diabetic mice had significantly less albuminuria and mesangial matrix expansion than the WT diabetic mice. TGF1 and renin gene expression and protein were substantially increased in the WT diabetic mice but not in USF1 / diabetic mice. The underlying pathway by which USF1 is regulated by high glucose was investigated in mesangial cell culture. High glucose inhibited AMP-activated protein kinase (AMPK) activity and increased USF1 nuclear translocation. Activation of AMPK with AICAR stimulated AMPK activity and reduced nuclear accumulation of USF1. We thus conclude that USF1 is a critical transcription factor regulating diabetic kidney disease and plays a critical role in albuminuria, mesangial matrix accumulation, and TGF1 and renin stimulation in diabetic kidney disease. AMPK activity may play a key role in high glucose-induced regulation of USF1.